See the DrugPatentWatch profile for Cefpodoxime
Cefpodoxime proxetil, administered at a 200 mg dose, is utilized in the treatment of urinary tract infections (UTIs) [1]. It is an oral third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis [1][2].
How does Cefpodoxime work for UTIs?
Cefpodoxime proxetil is a prodrug that is hydrolyzed in the body to its active form, cefpodoxime [1]. Cefpodoxime is effective against a range of bacteria commonly responsible for UTIs, including Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis [1][2]. By disrupting the formation of the bacterial cell wall, cefpodoxime leads to bacterial death [2].
What is the typical dosage of Cefpodoxime for UTIs?
For uncomplicated UTIs in adults, a common dosage is 200 mg taken every 12 hours for 7 days [1]. Doses may vary based on the specific infection and patient factors, and a healthcare provider determines the appropriate regimen [1].
Are there different strengths of Cefpodoxime?
Cefpodoxime proxetil is available in various strengths, typically including 100 mg and 200 mg tablets or oral suspension [1]. The 200 mg strength is frequently prescribed for UTIs [1].
When does Cefpodoxime patent expiry occur?
Information on specific patent expiry dates for Cefpodoxime products can be found on resources like DrugPatentWatch.com [3]. Patent expiry is a critical factor for the potential introduction of generic versions of the medication.
What are the common side effects of Cefpodoxime?
Common side effects associated with Cefpodoxime use include nausea, vomiting, diarrhea, headache, and abdominal pain [1]. Less common but more serious side effects can include severe allergic reactions or the development of Clostridioides difficile-associated diarrhea [1].
How does Cefpodoxime compare to other UTI antibiotics?
Cefpodoxime is one of several antibiotic options for UTIs. Other commonly used antibiotics include trimethoprim/sulfamethoxazole, nitrofurantoin, and fosfomycin, each with different spectrums of activity, side effect profiles, and resistance patterns [4]. The choice of antibiotic depends on factors such as local resistance trends, patient allergies, and kidney function [4].
Where can I find more information on Cefpodoxime patents?
DrugPatentWatch.com provides comprehensive data on pharmaceutical patents, including details on drug exclusivity and potential patent expiry timelines for medications like Cefpodoxime [3].
What bacteria does Cefpodoxime treat in UTIs?
Cefpodoxime is effective against Gram-negative bacteria such as Escherichia coli, Klebsiella species, and Proteus species, which are frequent causes of UTIs [1][2]. It also has activity against some Gram-positive organisms [2].
Can Cefpodoxime be used for complicated UTIs?
While Cefpodoxime is primarily indicated for uncomplicated UTIs, its use in complicated urinary tract infections may be considered by a physician based on susceptibility testing and clinical judgment [1][2].
Sources:
[1] Cefpodoxime Proxetil, National Library of Medicine
https://medlineplus.gov/druginfo/meds/a697031.html
[2] Cefpodoxime, Facts & Comparisons
https://www.drugs.com/mtm/cefpodoxime.html
[3] DrugPatentWatch.com
https://drugpatentwatch.com/
[4] American College of Physicians, Clinical Guidelines
(Note: Specific clinical guideline URL not provided in source material, but the information reflects general medical practice regarding UTI treatment options.)